Understanding Immunity to the COVID-19 Vaccines

COVID-19 Vaccine Induced Adaptive Immune Responses

NCT04729374 ·Status: UNKNOWN

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study

NCT05048849 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind

NCT05367908 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

NCT05216601 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

NCT04412538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

NCT05522829 ·Status: UNKNOWN ·Phase: PHASE2

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

NCT04824638 ·Status: COMPLETED ·Phase: PHASE2

Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine

NCT04944381 ·Status: UNKNOWN ·Phase: NA

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

NCT04910269 ·Status: RECRUITING ·Phase: PHASE3

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

NCT04582903 ·Status: RECRUITING

A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

NCT04967742 ·Status: COMPLETED ·Phase: PHASE1

SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine

NCT04952402 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19

NCT04487210 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

NCT05308602 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

NCT04352608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults

NCT05148091 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

NCT04944095 ·Status: UNKNOWN

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

NCT04545749 ·Status: COMPLETED ·Phase: PHASE1

ImmuneSense™ COVID-19 Study

NCT04583982 ·Status: COMPLETED

A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study

NCT05038618 ·Status: COMPLETED ·Phase: PHASE2

A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

NCT04640402 ·Status: COMPLETED ·Phase: PHASE2

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

NCT05652543 ·Status: COMPLETED ·Phase: PHASE2

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097 ·Status: COMPLETED ·Phase: PHASE2

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

NCT05258669 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3